Listed by the USPTO as BAGNAL, CINDY LILIANA
Tech Center 1600 • Art Units: 1621
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18874175 | CRYSTALINE FORMS OF A SYNTHETIC CANNABINOID | Non-Final OA | Jazz Pharmaceuticals Research UK Limited |
| 18868526 | MODULATION OF BACE1 AS A THERAPY FOR SPINOCEREBELLAR ATAXIA | Non-Final OA | Rudolph E. TANZI |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your StrategyCindy Liliana Bagnal examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
